Revisiting beta thalassemia intermedia: past, present, and future prospects

Area of Science:

• Hematology
• Genetics
• Internal Medicine

Background:

• Thalassemias range from mild (minor) to severe, transfusion-dependent (major).
• Thalassemia intermedia (TI) presents with mild to moderate anemia.
• TI's distinct pathophysiology and clinical course differentiate it from thalassemia major.

Purpose of the Study:

• To outline the genetic characteristics of TI.
• To detail major clinical complications associated with TI.
• To review current and emerging therapeutic strategies for TI management.

Main Methods:

• Literature search conducted on Medline.
• Focused on publications from relevant scientific journals.

Main Results:

• Understanding of TI pathophysiology and molecular basis has advanced.
• TI exhibits greater morbidity and a broader spectrum of organ dysfunction than previously recognized.
• Clinical presentation and complications of TI are distinct from thalassemia major.

Conclusions:

• TI is a serious condition, not mild, driven by ineffective erythropoiesis, chronic anemia, and iron overload.
• These pathophysiologic factors contribute to the diverse clinical manifestations of TI.
• Ongoing research aims to expand therapeutic options for managing TI.